A.A. Khazhnagoeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A.A. Khazhnagoeva has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Albina A. Pshukova
Federal State Budgetary Educational Institution of Higher Education "Kabardino- Balkarian State University named after H.M. Berbekov" of the Ministry of Education and Science of the Russian Federation, Nalchik, Russia
2 shared publications - Azis V. Akhokhova
Federal State Budgetary Educational Institution of Higher Education "Kabardino-Balkarian State University named after H.M. Berbekov", 360004, Nalchik, Russian Federation
2 shared publications - A.B. Tkhabisimova
Berbekov Kabardino-Balkarian State University
1 shared publication - D.A. Shukurova
Medical Academy, Department of General Medical Training and Medical Rehabilitation, Nalchik, Russian Federation
1 shared publication - Irina Korneevna Tkhabisimova
Kabardino-Balkarian State University named after H.M. Berbekov
1 shared publication - M. Zh. Attaeva
Federal State Budgetary Educational Institution of Higher Education "Kabardino-Balkarian State University named after H.M. Berbekov", 360004, Nalchik, Russian Federation
1 shared publication
Latest Publications
- 27 May 2026
- Published by PANORAMA Publishing House
- No. 5,p. 18-27
Monitoring divergence index as a tool for early detection of latent risk in a regional anti-drug system
Regional monitoring of the drug situation often describes registered cases but is less sensitive to hidden risk accumulation when acute toxicological events begin to diverge from registration-based detection. The aim of the study was to substantiate the monitoring divergence index as a tool for early detection of latent risk in a regional anti-drug system and to demonstrate its applied value using data from the Kabardino-Balkarian Republic for 2014-2024. The study was designed as a conceptual and empirical analysis based on aggregated annual data from federal statistical reporting form No. 11 and information on acute poisonings related to narcotic drugs and psychoactive substances; no individual patient data were employed. The index was calculated as the ratio of acute toxicological events to newly detected cases of drug addiction in the same year. Values below 0.5 were interpreted as a balanced monitoring regime, 0.5-1.5 as an instability zone, and values above 1.5 as pronounced divergence. In 2016-2019, the index remained low (0.21-0.34); in 2020-2021, it shifted to the instability zone, and in 2024 it reached 1.68. The increase in the index should not be treated as an independent diagnosis; rather, it should trigger managerial verification, including comparison of registration and toxicological sources, route audit, assessment of decision-making delays, and adjustment of interagency response. The proposed indicator increases the sensitivity of monitoring to latent risk and may be used as an element of early prevention, provided that regional thresholds are calibrated and externally validated. Its application is particularly important for management discussions prior to the clinical manifestation of instability.
- 27 May 2026
- Published by PANORAMA Publishing House
- No. 5,p. 18-27
Monitoring divergence index as a tool for early detection of latent risk in a regional anti-drug system
Regional monitoring of the drug situation often describes registered cases but is less sensitive to hidden risk accumulation when acute toxicological events begin to diverge from registration-based detection. The aim of the study was to substantiate the monitoring divergence index as a tool for early detection of latent risk in a regional anti-drug system and to demonstrate its applied value using data from the Kabardino-Balkarian Republic for 2014-2024. The study was designed as a conceptual and empirical analysis based on aggregated annual data from federal statistical reporting form No. 11 and information on acute poisonings related to narcotic drugs and psychoactive substances; no individual patient data were employed. The index was calculated as the ratio of acute toxicological events to newly detected cases of drug addiction in the same year. Values below 0.5 were interpreted as a balanced monitoring regime, 0.5-1.5 as an instability zone, and values above 1.5 as pronounced divergence. In 2016-2019, the index remained low (0.21-0.34); in 2020-2021, it shifted to the instability zone, and in 2024 it reached 1.68. The increase in the index should not be treated as an independent diagnosis; rather, it should trigger managerial verification, including comparison of registration and toxicological sources, route audit, assessment of decision-making delays, and adjustment of interagency response. The proposed indicator increases the sensitivity of monitoring to latent risk and may be used as an element of early prevention, provided that regional thresholds are calibrated and externally validated. Its application is particularly important for management discussions prior to the clinical manifestation of instability.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Healthcare Management: News. Views. Education. Bulletin of VSHOUZ
- Vol. 10 (1)
Some issues of regulation of the order No. 116n of the Ministry of Health of the Russian Federation «On approval of the procedure for providing medical care to the adult population with cancer» from the perspective of regional experience
Некоторые вопросы регламентации приказа № 116н Минздрава России
- 1 January 2024
- Published by Geotar-Media Publishing Group in Healthcare Management: News. Views. Education. Bulletin of VSHOUZ
- Vol. 10 (1)
Open AccessSome issues of regulation of the order No. 116n of the Ministry of Health of the Russian Federation «On approval of the procedure for providing medical care to the adult population with cancer» from the perspective of regional experience
Некоторые вопросы регламентации приказа № 116н Минздрава России